Skip to Main Content

Paper Details

Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
Clin Infect Dis
16
2022
Author NameAffiliation
Victor B TalisaVA Pittsburgh Healthcare System
Victor B TalisaUniversity of Pittsburgh School of Medicine
Victor B TalisaUniversity of Pittsburgh
Saad B OmerYale Institute for Global Health, Yale School of Medicine
  • 1 - 4

Datasets

Release 1.2